BlackRock’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,186
| Closed | -$14.4K | – | 5480 |
|
|
2024
Q3 | $14.4K | Hold |
7,186
| – | – | ﹤0.01% | 4968 |
|
|
2024
Q2 | $11.9K | Sell |
7,186
-613
| -8% | -$1.61K | ﹤0.01% | 5052 |
|
|
2024
Q1 | $47.1K | Sell |
7,799
-728
| -9% | -$4.76K | ﹤0.01% | 4882 |
|
|
2023
Q4 | $59.9K | Buy |
8,527
+4
| +0% | +$31 | ﹤0.01% | 4933 |
|
|
2023
Q3 | $74.6K | Sell |
8,523
-33
| -0.4% | -$309 | ﹤0.01% | 4917 |
|
|
2023
Q2 | $101K | Sell |
8,556
-2,382
| -22% | -$34.2K | ﹤0.01% | 4908 |
|
|
2023
Q1 | $187K | Buy |
10,938
+546
| +5% | +$11.8K | ﹤0.01% | 4795 |
|
|
2022
Q4 | $273K | Buy |
10,392
+27
| +0.3% | +$1.28K | ﹤0.01% | 4764 |
|
|
2022
Q3 | $1.05M | Sell |
10,365
-75
| -0.7% | -$10.1K | ﹤0.01% | 4460 |
|
|
2022
Q2 | $1.48M | Buy |
10,440
+133
| +1% | +$18.6K | ﹤0.01% | 4376 |
|
|
2022
Q1 | $1.63M | Buy |
10,307
+7
| +0.1% | +$1.13K | ﹤0.01% | 4472 |
|
|
2021
Q4 | $2.28M | Sell |
10,300
-71
| -0.7% | -$13.7K | ﹤0.01% | 4350 |
|
|
2021
Q3 | $2M | Sell |
10,371
-90
| -0.9% | -$19.1K | ﹤0.01% | 4324 |
|
|
2021
Q2 | $2.51M | Sell |
10,461
-936
| -8% | -$257K | ﹤0.01% | 4162 |
|
|
2021
Q1 | $3.87M | Buy |
11,397
+203
| +2% | +$82.5K | ﹤0.01% | 4056 |
|
|
2020
Q4 | $4.01M | Buy |
11,194
+1,026
| +10% | +$395K | ﹤0.01% | 3795 |
|
|
2020
Q3 | $4.7M | Buy |
10,168
+8,068
| +384% | +$2.28M | ﹤0.01% | 3600 |
|
|
2020
Q2 | $302K | Buy |
2,100
+1,215
| +137% | +$154K | ﹤0.01% | 4297 |
|
|
2020
Q1 | $84K | Buy |
885
+387
| +78% | +$46K | ﹤0.01% | 4385 |
|
|
2019
Q4 | $67K | Buy |
+498
| New | +$63.9K | ﹤0.01% | 4501 |
|
Other funds holding TFFP
BlackRock's TFFP Position: Q4 2024 in Review
BlackRock sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 7,186 shares — an estimated $14.4K sold.
BlackRock first reported a position in TFFP in Q4 2019 and held it in 20 quarters. The position peaked at $4.7M in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- BlackRock reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- BlackRock sold 7,186 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $14.4K.
- BlackRock first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 20 quarters.
- BlackRock's TFF Pharmaceuticals, Inc. Common Stock position peaked at $4.7M in Q3 2020.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.